seqWell
Michael Finney is a Board Member at seqWell who has previous experience as a Board Chair at Addition Therapeutics and Director at Vaxart Inc. (NASDAQ: VXRT).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
seqWell
seqWell was created to revolutionize NGS library prep to unlock the full potential of today’s DNA sequencing instruments. Its plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization.